TY - JOUR
T1 - Role of adiponectin gene variants, adipokines and hydrometry-based percent body fat in metabolically healthy and abnormal obesity
AU - Chang, Chin Sung
AU - Lu, Yan Jia
AU - Chang, Hsiu Hao
AU - Hsu, Shih Han
AU - Kuo, Po Hsiu
AU - Shieh, Chi Chang
AU - Yao, Wei Jen
AU - Hsu, Mei Chi
AU - Young, Kung Chia
AU - Lin, Wen Yuan
AU - Huang, Kuo Chin
AU - Wu, Chih Hsing
AU - Tsai, Yau Sheng
N1 - Publisher Copyright:
© 2016 Asia Oceania Association for the Study of Obesity
PY - 2018/1
Y1 - 2018/1
N2 - Objective: Metabolically healthy obesity (MHO) subjects have better metabolic parameters than metabolically abnormal obesity (MAO) subjects, but the possible mechanisms underlying this remain unknown. Our study was designed to investigate the interrelationships among genes, adipokines, body fat and its distribution in MHO and MAO. Methods: From 2007 to 2009, 103 males and 131 females aged 18–50 years were enrolled by an intention-to-treat design in a weight management clinic. Participants were divided into MHO and MAO groups. Percent body fat (PBF) was measured by a deuterium oxide dilution method. Four polymorphic variants, including PPARγ2 (Pro12Ala and C1431T) and adiponectin (T45G and G276T) genes, and three adipokines (adiponectin, leptin and resistin) were obtained. Results: Of the 234 obese subjects, 130 (55.6%) were MHO. In the univariate analysis, the MAO group has significantly higher anthropometric, metabolic indices and leptin levels than the MHO group. Logistic regression analysis revealed that age, male gender, the T allele of adiponectin T45G polymorphism, leptin and PBF were positively associated with MAO. ANCOVA analysis revealed that the T allele of adiponectin T45G polymorphism was associated with higher fasting and postprandial glucose levels. We further found that TT genotype has a lower high molecular weight (HMW)/low molecular weight (LMW) adiponectin ratio than GG genotype. Conclusions: The factors associated with MAO are age, male gender, the T allele of adiponectin T45G polymorphism, leptin, and PBF. The net effects of T45G polymorphism on the MAO phenotype may be achieved by changes in the adiponectin oligomer ratio and glucose levels.
AB - Objective: Metabolically healthy obesity (MHO) subjects have better metabolic parameters than metabolically abnormal obesity (MAO) subjects, but the possible mechanisms underlying this remain unknown. Our study was designed to investigate the interrelationships among genes, adipokines, body fat and its distribution in MHO and MAO. Methods: From 2007 to 2009, 103 males and 131 females aged 18–50 years were enrolled by an intention-to-treat design in a weight management clinic. Participants were divided into MHO and MAO groups. Percent body fat (PBF) was measured by a deuterium oxide dilution method. Four polymorphic variants, including PPARγ2 (Pro12Ala and C1431T) and adiponectin (T45G and G276T) genes, and three adipokines (adiponectin, leptin and resistin) were obtained. Results: Of the 234 obese subjects, 130 (55.6%) were MHO. In the univariate analysis, the MAO group has significantly higher anthropometric, metabolic indices and leptin levels than the MHO group. Logistic regression analysis revealed that age, male gender, the T allele of adiponectin T45G polymorphism, leptin and PBF were positively associated with MAO. ANCOVA analysis revealed that the T allele of adiponectin T45G polymorphism was associated with higher fasting and postprandial glucose levels. We further found that TT genotype has a lower high molecular weight (HMW)/low molecular weight (LMW) adiponectin ratio than GG genotype. Conclusions: The factors associated with MAO are age, male gender, the T allele of adiponectin T45G polymorphism, leptin, and PBF. The net effects of T45G polymorphism on the MAO phenotype may be achieved by changes in the adiponectin oligomer ratio and glucose levels.
UR - http://www.scopus.com/inward/record.url?scp=84969592387&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969592387&partnerID=8YFLogxK
U2 - 10.1016/j.orcp.2016.05.003
DO - 10.1016/j.orcp.2016.05.003
M3 - Article
C2 - 27236826
AN - SCOPUS:84969592387
SN - 1871-403X
VL - 12
SP - 49
EP - 61
JO - Obesity Research and Clinical Practice
JF - Obesity Research and Clinical Practice
IS - 1
ER -